RejuvenAir
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
131 Hartwell Ave Ste 100, Lexington, Mas...Phone Number
(781) 538-4720Website
www.rejuvenair.comRevenue
$30.1 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About RejuvenAir
RejuvenAir is a medical device company focused on developing innovative cryotherapy solutions for the treatment of Chronic Bronchitis, a subset of Chronic Obstructive Pulmonary Disease (COPD). Their flagship product, the RejuvenAir System, utilizes a unique metered cryospray technology to target and destroy damaged cells in the lungs, promoting the regrowth of healthy airway cells. The company is currently conducting the SPRAY-CB clinical trial to evaluate the effectiveness of their device in reducing symptoms and improving the quality of life for patients suffering from Chronic Bronchitis. RejuvenAir aims to provide a breakthrough treatment option that addresses the underlying causes of the disease rather than just alleviating symptoms.Explore more
RejuvenAir Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RejuvenAir your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if RejuvenAir is spiking on competitors!
RejuvenAir, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on RejuvenAir recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if RejuvenAir had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at RejuvenAir
Check if RejuvenAir has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when RejuvenAir launches new products
Funding: Get notified immidiatlly once RejuvenAir has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to RejuvenAir
Compare insights from companies similar to RejuvenAir, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RejuvenAir is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RejuvenAir is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RejuvenAir.
RejuvenAir financials insights
Gather financial insights about RejuvenAir, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Series C
$16M
2015
Debt
$2.9M
Debt
$6.6M
2016
Debt
$2.9M
2017
Debt
$4.2M
2018
Debt
$15M
2020
Debt
$1M
2024
Series D
$53M
RejuvenAir Tech Stack
A closer look at the technologies used by RejuvenAir
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
CSA Medical Inc has received an SBA PPP loan for $1-2 million from Pacific Western Bank.
Left Company
Daniel Grasso, Research Engineer II, has left the organization.
Personnel Moves, Left Company
Funding
Funding
RejuvenAir News & Media
CSA Medical Announces New Scientific Data Utilizing Metered Cryospray with the RejuvenAir® System for the Treatment of Chronic Bronchitis
Research reveals rejuvenative changes in cellular populations indicative of airway remodeling correspond with clinical efficacy and improved quality of life BOSTON, Sept. 16, 2024 /PRNewswire/ -- CSA Medical, Inc., today announced multiple presentations at the European Respiratory Society...CSA Medical Raises $53 Million in Series D Financing to Support PMA of the RejuvenAir System
TVM Capital Life Science and Yonjin Venture co-led the round, joined by a strong syndicate of existing investors BOSTON, Sept. 9, 2024 /PRNewswire/ -- CSA Medical Inc., developer of The RejuvenAir® System, a Breakthrough Medical Device advancing the power of liquid nitrogen spray...CSA Medical Completes Enrollment in SPRAY-CB, a U.S. Pivotal Trial of The RejuvenAir System for the Treatment of Chronic Bronchitis
The RejuvenAir® System, utilizing Metered Cryospray, delivers a minimally invasive medical device therapy which aims to target the underlying cause of COPD with Chronic Bronchitis BOSTON, July 8, 2024 /PRNewswire/ -- CSA Medical Inc., developer of The RejuvenAir® System, a medical device...CSA Medical Announces 500th Metered CryoSpray Procedure for the Treatment of Chronic Bronchitis
The RejuvenAir System is a minimally invasive medical device therapy which aims to target the underlying cause of COPD with Chronic Bronchitis BOSTON, Feb. 7, 2024 /PRNewswire/ -- CSA Medical Inc., a developer of medical devices advancing the power of liquid nitrogen spray cryotherapy,...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RejuvenAir
Sign Up For FreeTo access detailed company insights
RejuvenAir is a medical device company focused on developing innovative cryotherapy solutions for the treatment of Chronic Bronchitis, a subset of Chronic Obstructive Pulmonary Disease (COPD). Their flagship product, the RejuvenAir System, utilizes a unique metered cryospray technology to target and destroy damaged cells in the lungs, promoting the... Read More
